- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.01. | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | - | SEC Filings | ||
| 06.01. | Nasdaq grants Revelation Biosciences' request for continued listing | 1 | Seeking Alpha | ||
| 06.01. | Nasdaq Grants Revelation Biosciences Inc. Continued Listing | 15 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained... ► Artikel lesen | |
| 02.01. | Pre-market Movers: Revelation Biosciences, Alset, Alternus Clean Energy, Neumora Therapeutics, Oriental Rise | 643 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.55 A.M. ET).In the Green Revelation Biosciences, Inc. (REVB) is up over 125%... ► Artikel lesen | |
| 02.01. | Revolution Beauty Group (LON:REVB) Trading Up 12.7% - Here's Why | 5 | MarketBeat | ||
| 19.12.24 | Revelation Biosciences stock hits 52-week low at $0.32 | 2 | Investing.com | ||
| REVELATION BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 19.12.24 | Revelation Biosciences-Aktie erreicht 52-Wochen-Tief bei 0,32 US-Dollar | 1 | Investing.com Deutsch | ||
| 12.12.24 | Revelation Biosciences files for secondary offering of common stock | 2 | Seeking Alpha | ||
| 11.12.24 | Aktie von Revelation Biosciences erreicht 52-Wochen-Tief bei 0,42 US-Dollar | 4 | Investing.com Deutsch | ||
| 11.12.24 | Revelation Biosciences stock hits 52-week low at $0.42 | 1 | Investing.com | ||
| 06.12.24 | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.24 | Why Revelation Biosciences (REVB) Stock Is Down 38% | 6 | Benzinga.com | ||
| 03.12.24 | Revelation Biosciences stock hits 52-week low at $0.7 | 3 | Investing.com | ||
| 03.12.24 | Revelation Biosciences-Aktie erreicht 52-Wochen-Tief bei 0,7 US-Dollar | 2 | Investing.com Deutsch | ||
| 02.12.24 | FDA approves Revelation Biosciences' drug trial for CKD | 3 | Investing.com | ||
| 11.11.24 | Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket | 3 | Benzinga.com | ||
| 08.11.24 | Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024 | 240 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity... ► Artikel lesen | |
| 08.11.24 | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | - | SEC Filings | ||
| 08.11.24 | REVELATION BIOSCIENCES, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 21.10.24 | Revelation Biosciences faces Nasdaq delisting over noncompliance | 2 | Investing.com |
Seite:
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TENAX THERAPEUTICS | 2,770 | 0,00 % | Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update | Raised Gross Proceeds of Approximately $100 Million in a Private Placement with Leading Institutional Healthcare Investors Continuing to Enroll Patients in Phase 3 LEVEL Study with 52 Investigative... ► Artikel lesen | |
| ARCADIA BIOSCIENCES | 4,820 | -1,23 % | Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction | DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when... ► Artikel lesen | |
| TRACON PHARMACEUTICALS | 1,410 | 0,00 % | TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces it Will Wind Down Operations | SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was... ► Artikel lesen | |
| ALZAMEND NEURO | 1,140 | -0,87 % | Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs | ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company, focused on developing novel products for the treatment of Alzheimer's disease... ► Artikel lesen | |
| ARIDIS PHARMACEUTICALS | - | - | Aridis Pharmaceuticals, Inc.: Aridis Provides Corporate Update | LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) ("Aridis" or the "Company"), a biopharmaceutical company, today announced a corporate update on recent... ► Artikel lesen | |
| QIAGEN | 44,935 | +0,65 % | EQS-Adhoc: QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück | EQS-Ad-hoc: QIAGEN N.V. / Schlagwort(e): Aktienrückkauf
QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück... ► Artikel lesen | |
| KEROS THERAPEUTICS | 10,860 | +3,04 % | Deep Dive Into Keros Therapeutics Stock: Analyst Perspectives (11 Ratings) | ||
| BIONTECH | 109,20 | +0,18 % | BioNTech Aktie testet Widerstände: Kommt der nächste Ausbruch? | Die BioNTech Aktie befindet sich in einer spannenden charttechnischen Phase mit einem NASDAQ-Schlusskurs vom Freitag bei 122,85 US-Dollar und einer insgesamt positiven Entwicklung seit Mitte des Jahres.... ► Artikel lesen | |
| EVOTEC | 7,990 | +3,30 % | Evotec, flatexDEGIRO, Hypoport, K+S, Puma, United Internet u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| NURIX THERAPEUTICS | 19,140 | -1,80 % | Nurix Therapeutics, Inc. - 8-K, Current Report | ||
| TEMPUS AI | 35,150 | +1,15 % | Tempus AI Inc (TEM): AI-Driven Healthcare Revolution | ||
| SUMMIT THERAPEUTICS | 19,020 | +4,56 % | Looking At Summit Therapeutics' Recent Unusual Options Activity | ||
| ADMA BIOLOGICS | 16,000 | -3,79 % | ADMA BIOLOGICS, INC. - 8-K, Current Report | ||
| DAY ONE BIOPHARMACEUTICALS | 12,540 | +1,13 % | Day One Biopharmaceuticals, Inc. - 8-K, Current Report | ||
| SPRINGWORKS THERAPEUTICS | 34,590 | -2,81 % | Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A | Goal to accelerate development and commercialization of the lead asset RPT04402 for the treatment of a subset of uterine cancersFinancials include a $13 million upfront payment and potential... ► Artikel lesen |
Das Unternehmen REVELATION BIOSCIENCES INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -3,73 % bei einem Aktienkurs von 0,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu REVELATION BIOSCIENCES INC finden Sie auf Wallstreet Online.
